The observed early phase of human colonocytes’ response to bacteria and phytate hydrolysate showed that the hydrolysate has the potential to reduce the secretion of proinflammatory IL-8 in cancer cells while being neutral for the healthy bacteria-treated colonocytes. The gene discussed is CXCL8; the disease is cancer.